Private Overactive Bladder Specialist in Enfield – Expert Care at Cavell Hospital

Three years on a single anticholinergic without adequate control suggests either that the dose needs adjustment, that a different medication class (mirabegron) would be more effective, that combination therapy should be considered, or that Botox injection is the appropriate next step. At Cavell Hospital, Dr. Godbole's assessment reviews your medication history, performs a repeat bladder diary, and recommends the most appropriate escalation — rather than continuing an inadequate prescription indefinitely.

This is clinically important. Oxybutynin — the most commonly prescribed anticholinergic — crosses the blood-brain barrier and worsens cognitive function, particularly in older patients with pre-existing cognitive impairment. It is specifically listed as potentially inappropriate in patients over 65 with cognitive concerns on the STOPP criteria. At Cavell Hospital, Dr. Godbole's assessment for older patients with cognitive concerns specifically avoids oxybutynin, preferring mirabegron (which has no anticholinergic effects) or bladder-selective antimuscarinics such as solifenacin or darifenacin with lower CNS penetration.

Urgency incontinence is leakage associated with a sudden, strong urge to urinate — the bladder contracts involuntarily before reaching the toilet. Stress incontinence is leakage caused by physical activity, coughing, sneezing, or laughing — increased abdominal pressure overwhelms the urethral sphincter. These require completely different treatments: bladder training and antimuscarinics/Botox for urgency incontinence; pelvic floor exercises and potentially mid-urethral sling surgery for stress incontinence. A bladder diary distinguishes between them clearly, and urodynamics confirms the diagnosis when mixed incontinence makes the distinction unclear.

NHS GP OAB management typically provides: antimuscarinics prescribed empirically without bladder diary. Private specialist OAB assessment at Cavell Hospital provides: bladder diary, OAB-q questionnaire, exclusion of UTI, bladder cancer and neurological causes, urodynamics where indicated, structured medication review with escalation pathway, and access to Botox injection for refractory cases. The specialist pathway produces better outcomes and earlier access to the full treatment ladder.

Yes — urinary retention (inability to pass urine) affects approximately 5–10% of patients after Botox bladder injection. The risk is higher in men with pre-existing voiding difficulty and in patients with neurogenic OAB. The standard management is clean intermittent self-catheterisation (CISC) — patients are taught to insert a small catheter 2–4 times daily to drain the bladder. Most patients requiring CISC after Botox find it manageable and prefer it to continued urgency incontinence. The risk of urinary retention is disclosed and CISC is taught at Cavell Hospital before Botox injection is performed.